Comments
HDFC Securities
Sudarshan Chemicals (Buy)
Target: ₹800
CMP:₹666
We expect Sudarshan Chemical Industries’ PAT to grow at a 32 per cent CAGR over FY21-23, led by a 20 per cent CAGR in revenue. Two major global players shifting away from the pigment business could act as a tailwind for Indian pigment manufacturers.
We believe SCIL is in a sweet spot to seize this opportunity by offering products similar to those of global players. Q4-EBITDA/APAT were 36/31 per cent above our estimates, mainly due to a 27 per cent higher revenue, lower-than-expected employee cost, offset by higher-than-expected tax outgo.
Concall takeaways: Exports accounted for 49 per cent of revenues for the pigment segment; Specialty pigments constituted 68 per cent of the revenues for pigment segment in Q4; The company’s Capex is planned to build and concentrate on increasing specialty pigments in its mix; It is about to finish its Capex plan of ₹600 crore in FY22; Sales from the total Capex will ramp up gradually over 3-4 years. This Capex has a revenue potential ₹1,000-1,200 crore at full capacity. Additional Capex for FY22 is ₹135 crore, which will be used to build infrastructure; and raw material price inflation is about 2-2.5 per cent.
We raise our FY22/23 EPS estimate by 52.2/40.9 per cent to ₹30.2/35.6 to account for the overall performance in FY21.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.